159 related articles for article (PubMed ID: 35481647)
1. Relative domain orientation of the L289K HIV-1 reverse transcriptase monomer.
Xi Z; Ilina TV; Guerrero M; Fan L; Sluis-Cremer N; Wang YX; Ishima R
Protein Sci; 2022 May; 31(5):e4307. PubMed ID: 35481647
[TBL] [Abstract][Full Text] [Related]
2. Homodimerization of the p51 subunit of HIV-1 reverse transcriptase.
Zheng X; Mueller GA; Cuneo MJ; Derose EF; London RE
Biochemistry; 2010 Apr; 49(13):2821-33. PubMed ID: 20180596
[TBL] [Abstract][Full Text] [Related]
3. Spatial domain organization in the HIV-1 reverse transcriptase p66 homodimer precursor probed by double electron-electron resonance EPR.
Schmidt T; Schwieters CD; Clore GM
Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17809-17816. PubMed ID: 31383767
[TBL] [Abstract][Full Text] [Related]
4. The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase decreases binding to nevirapine.
Schuckmann MM; Marchand B; Hachiya A; Kodama EN; Kirby KA; Singh K; Sarafianos SG
J Biol Chem; 2010 Dec; 285(49):38700-9. PubMed ID: 20876531
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic processing of an HIV-1 pol polyprotein precursor: insights into the mechanism of reverse transcriptase p66/p51 heterodimer formation.
Sluis-Cremer N; Arion D; Abram ME; Parniak MA
Int J Biochem Cell Biol; 2004 Sep; 36(9):1836-47. PubMed ID: 15183348
[TBL] [Abstract][Full Text] [Related]
6. p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors.
Dufour E; El Dirani-Diab R; Boulmé F; Fournier M; Nevinsky G; Tarrago-Litvak L; Litvak S; Andreola ML
Eur J Biochem; 1998 Jan; 251(1-2):487-95. PubMed ID: 9492322
[TBL] [Abstract][Full Text] [Related]
7. Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.
Mulky A; Sarafianos SG; Arnold E; Wu X; Kappes JC
J Virol; 2004 Jul; 78(13):7089-96. PubMed ID: 15194785
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer.
Wang J; Smerdon SJ; Jäger J; Kohlstaedt LA; Rice PA; Friedman JM; Steitz TA
Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7242-6. PubMed ID: 7518928
[TBL] [Abstract][Full Text] [Related]
9. Conformational Changes in HIV-1 Reverse Transcriptase that Facilitate Its Maturation.
Slack RL; Ilina TV; Xi Z; Giacobbi NS; Kawai G; Parniak MA; Sarafianos SG; Sluis Cremer N; Ishima R
Structure; 2019 Oct; 27(10):1581-1593.e3. PubMed ID: 31471129
[TBL] [Abstract][Full Text] [Related]
10. The p66 immature precursor of HIV-1 reverse transcriptase.
Sharaf NG; Poliner E; Slack RL; Christen MT; Byeon IJ; Parniak MA; Gronenborn AM; Ishima R
Proteins; 2014 Oct; 82(10):2343-52. PubMed ID: 24771554
[TBL] [Abstract][Full Text] [Related]
11. The mutation T477A in HIV-1 reverse transcriptase (RT) restores normal proteolytic processing of RT in virus with Gag-Pol mutated in the p51-RNH cleavage site.
Abram ME; Sarafianos SG; Parniak MA
Retrovirology; 2010 Feb; 7():6. PubMed ID: 20122159
[TBL] [Abstract][Full Text] [Related]
12. The beta7-beta8 loop of the p51 subunit in the heterodimeric (p66/p51) human immunodeficiency virus type 1 reverse transcriptase is essential for the catalytic function of the p66 subunit.
Pandey PK; Kaushik N; Talele TT; Yadav PN; Pandey VN
Biochemistry; 2001 Aug; 40(32):9505-12. PubMed ID: 11583149
[TBL] [Abstract][Full Text] [Related]
13. Efavirenz binding to HIV-1 reverse transcriptase monomers and dimers.
Braz VA; Holladay LA; Barkley MD
Biochemistry; 2010 Jan; 49(3):601-10. PubMed ID: 20039714
[TBL] [Abstract][Full Text] [Related]
14. Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase.
Boyer PL; Ding J; Arnold E; Hughes SH
Antimicrob Agents Chemother; 1994 Sep; 38(9):1909-14. PubMed ID: 7529011
[TBL] [Abstract][Full Text] [Related]
15. Binding kinetics and affinities of heterodimeric versus homodimeric HIV-1 reverse transcriptase on DNA-DNA substrates at the single-molecule level.
Marko RA; Liu HW; Ablenas CJ; Ehteshami M; Götte M; Cosa G
J Phys Chem B; 2013 Apr; 117(16):4560-7. PubMed ID: 23305243
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus type 1 reverse transcriptase dimer destabilization by 1-[Spiro[4"-amino-2",2" -dioxo-1",2" -oxathiole-5",3'-[2', 5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]]]-3-ethylthy mine.
Sluis-Cremer N; Dmitrienko GI; Balzarini J; Camarasa MJ; Parniak MA
Biochemistry; 2000 Feb; 39(6):1427-33. PubMed ID: 10684624
[TBL] [Abstract][Full Text] [Related]
17. Biophysical Characterization of p51 and p66 Monomers of HIV-1 Reverse Transcriptase with Their Inhibitors.
Seetaha S; Kamonsutthipaijit N; Yagi-Utsumi M; Seako Y; Yamaguchi T; Hannongbua S; Kato K; Choowongkomon K
Protein J; 2023 Dec; 42(6):741-752. PubMed ID: 37728788
[TBL] [Abstract][Full Text] [Related]
18. The HIV-1 p66 homodimeric RT exhibits different conformations in the binding-competent and -incompetent NNRTI site.
Sharaf NG; Xi Z; Ishima R; Gronenborn AM
Proteins; 2017 Dec; 85(12):2191-2197. PubMed ID: 28905420
[TBL] [Abstract][Full Text] [Related]
19. Structure/function studies of HIV-1(1) reverse transcriptase: dimerization-defective mutant L289K.
Goel R; Beard WA; Kumar A; Casas-Finet JR; Strub MP; Stahl SJ; Lewis MS; Bebenek K; Becerra SP; Kunkel TA
Biochemistry; 1993 Dec; 32(48):13012-8. PubMed ID: 7694651
[TBL] [Abstract][Full Text] [Related]
20. The amino acid Asn136 in HIV-1 reverse transcriptase (RT) maintains efficient association of both RT subunits and enables the rational design of novel RT inhibitors.
Balzarini J; Auwerx J; Rodríguez-Barrios F; Chedad A; Farkas V; Ceccherini-Silberstein F; García-Aparicio C; Velázquez S; De Clercq E; Perno CF; Camarasa MJ; Gago F
Mol Pharmacol; 2005 Jul; 68(1):49-60. PubMed ID: 15833734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
